Institute for Parasitology and Tropical Veterinary Medicine, Freie Universität Berlin, Robert-von-Ostertag-Str. 7, 14163, Berlin, Germany.
Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, L3 5RF, Liverpool, UK.
Int J Parasitol Drugs Drug Resist. 2023 Dec;23:94-105. doi: 10.1016/j.ijpddr.2023.11.001. Epub 2023 Nov 21.
Fasciola hepatica infections lead to severe health problems and production losses in sheep farming, if not treated effectively. Triclabendazole has been used extensively over decades due to its unique efficacy range against all definitive hostfluke stages but published data about the susceptibility of F. hepatica to anthelmintics in Germany are lacking. This study aimed to identify current F. hepatica infections in German sheep flocks by coproscopic examinations and to evaluate the efficacy of anthelmintics with a focus on triclabendazole in a field study conducted from 2020 to 2022. Initial screening included 71 sheep farms, many of them with known history of fasciolosis. In this highly biased sample set, the frequency of F. hepatica infection at individual sheep and farm level were 12.8% and 35.2%, respectively. Additionally, eggs of Paramphistominae were found at frequencies of 4.8% and 15.5% at individual sheep and farm level, respectively. Due to low egg shedding intensity, faecal egg count reduction (FECR) tests could only be conducted on a few farms. The efficacy of triclabendazole was tested on 11 farms and albendazole on one farm, including 3-53 sheep/farm. Individual faecal samples were collected before and two weeks after treatment to evaluate the FECR using the sedimentation or FLUKEFINDER® or a modified FLUKEFINDER® method. On all farms a coproantigen reduction test was conducted in parallel. Lacking efficacy of triclabendazole even at double dosage was shown on one farm associated with a high number of animal losses due to acute fasciolosis. On this farm, the Fasciola miracidium development test was additionally performed, revealing a high in vitro ovicidal activity of albendazole while closantel was effective in vivo. On all other farms, sufficient efficacy of triclabendazole was observed. In conclusion, triclabendazole resistance appears not to be widespread on German sheep farms but, when present, can have serious effects on animal health.
肝片吸虫感染如果得不到有效治疗,会给绵羊养殖带来严重的健康问题和生产损失。几十年来,三氯苯达唑因其对所有终宿主吸虫阶段的独特疗效而被广泛使用,但德国缺乏有关肝片吸虫对驱虫药敏感性的发表数据。本研究旨在通过粪便检查来确定德国绵羊群中当前的肝片吸虫感染情况,并在 2020 年至 2022 年进行的实地研究中评估驱虫药的疗效,重点是三氯苯达唑。初步筛选包括 71 个绵羊场,其中许多场有肝片吸虫病的已知病史。在这个高度偏向的样本集中,个体绵羊和农场水平的肝片吸虫感染频率分别为 12.8%和 35.2%。此外,个体绵羊和农场水平的双腔吸虫卵的检出率分别为 4.8%和 15.5%。由于粪便中虫卵排出强度低,仅在少数几个农场进行了粪便虫卵减少率(FECR)检测。在 11 个农场测试了三氯苯达唑的疗效,在 1 个农场测试了阿苯达唑的疗效,每个农场包括 3-53 只绵羊。在治疗前和治疗后两周采集个体粪便样本,使用沉淀法或 FLUKEFINDER®或改良的 FLUKEFINDER®方法评估 FECR。所有农场都同时进行了粪抗原减少试验。在一个与急性肝片吸虫病导致大量动物死亡相关的农场,即使使用双倍剂量,三氯苯达唑也显示出无效。在这个农场,还进行了肝片形吸虫尾蚴发育试验,结果显示阿苯达唑的体外杀卵活性很高,而氯硝柳胺在体内有效。在所有其他农场,三氯苯达唑都表现出足够的疗效。总之,三氯苯达唑耐药性在德国绵羊养殖场似乎并不普遍,但如果存在,会对动物健康产生严重影响。